2002 (9) TMI 306 - SC - Customs

Supreme Court Upholds Drug Dealers' Prosecution, Emphasizes Legal Defenses

The Supreme Court allowed the appeal, overturning the High Court's decision to quash criminal proceedings against accused dealers under the Drugs and ... Prosecution of dealers for sale of spurious drugs - liability under Section 18 for sale or distribution of drugs contravening the Act - defence under Section 19(1) and Section 19(3) of the Drugs and Cosmetics ActProsecution of dealers for sale of spurious drugs - liability under Section 18 for sale or distribution of drugs contravening the Act - defence under Section 19(1) and Section 19(3) of the Drugs and Cosmetics Act - Whether the criminal proceedings against the respondents (dealers) for offences under the Drugs and Cosmetics Act could be quashed on the ground that dealers cannot be prosecuted without making the manufacturer an accused. - HELD THAT: - The Court examined Section 17-B (spurious drugs) and Section 18 (prohibition of manufacture and sale) and held that the Act prohibits manufacture, sale, stock, exhibition or distribution of drugs in contravention of the Chapter, thereby attracting liability on persons who sell or distribute such drugs. The statutory defences are governed by Section 19: sub section (1) eliminates mere ignorance of the nature, substance or quality of the drug as a general defence, whereas sub section (3) affords a specific defence to a person not being the manufacturer if he proves acquisition from a duly licensed source, lack of knowledge and inability, with reasonable diligence, to have ascertained contravention, and proper storage and maintenance of the drug. The Court held that these provisions do not confer any bar on prosecuting a dealer in the absence of the manufacturer being made an accused. The availability of the limited defence under Section 19(3)(b) is to be considered after the prosecution adduces evidence; it does not warrant quashing proceedings at a preliminary stage. Reliance by the High Court on an earlier Division Bench decision and the Single Judge's conclusion that dealers could not be proceeded against without the manufacturer was contrary to the statutory scheme and therefore unsustainable. [Paras 7, 13, 14, 15]Impugned order quashing the criminal proceedings set aside; trial of Criminal Case No. 345 of 1999 restored to proceed in accordance with law.Final Conclusion: The appeal is allowed; the High Court order quashing the prosecution was erroneous as the Act permits prosecution of dealers and confines the available defence to the specific circumstances set out in Section 19(3); the trial is restored. Issues:- Interpretation of provisions of the Drugs and Cosmetics Act, 1940 regarding prosecution of dealers under Sections 17-B, 18(b) and (c).- Misunderstanding of the Act by the High Court leading to quashing of criminal proceedings.- Applicability of defence provisions under Section 19 of the Act to accused dealers.Analysis:The Supreme Court granted leave to appeal in a case where respondents were prosecuted under the Drugs and Cosmetics Act, 1940 for alleged offences. The High Court of Andhra Pradesh had quashed the criminal proceedings, leading to an appeal by the State. The State argued that the High Court misunderstood the Act and wrongly relied on a previous Division Bench decision. The Single Judge had held that dealers cannot be prosecuted without the manufacturer being accused. The Division Bench decision mentioned emphasized that dealers cannot be held liable if they purchased the drugs from valid distributors without knowledge of any contravention. The Supreme Court found the Single Judge's order overlooked the Act's provisions and the defence available to accused dealers under Section 19(3) of the Act.The Supreme Court analyzed the relevant sections of the Act, including Section 17-B on spurious drugs and Section 18 on the prohibition of manufacturing and sale of drugs. The Court highlighted that the defence available to accused dealers is outlined in Section 19(3), which requires them to prove lack of knowledge of any contravention despite reasonable diligence. The Court emphasized that the Act does not prohibit the prosecution of dealers without involving the manufacturer as a co-accused. The High Court's decision failed to consider the specific provisions of the Act that deny the defence plea based on ignorance of the drug's nature or quality.In conclusion, the Supreme Court allowed the appeal, setting aside the High Court's order and directing the trial court to proceed with the criminal case against the respondents. The Court clarified that the defence available to accused dealers should be considered after the prosecution presents its evidence, as per the provisions of the Act. The judgment emphasized the importance of interpreting the Act's provisions accurately and ensuring that all relevant legal defenses are applied appropriately during criminal proceedings.